I am pleased to share my latest article published by Forbes Business Council. The article discusses why artificial intelligence in genomic medicine should not be driven only by hype or technical excitement, but by strong governance, institutional responsibility, ethical safeguards, and careful clinical adoption. Read the full article here: https://www.forbes.com/councils/forbesbusinesscouncil/2026/05/07/ai-in-genomic-medicine-is-advancing-but-institutions-need-governance-not-

I am pleased to share that my expert response was selected for publication in a Forbes Business Council Expert Panel article. The article is now live on Forbes and discusses an important business topic: pricing power and how companies can protect it in a budget-conscious market https://www.forbes.com/councils/forbesbusinesscouncil/2026/05/15/pricing-power-how-to-protect-it-in-a-budget-conscious-market/. Being included in a Forbes Business Council Expert Panel is a meaningful

Dr. Habib Al Souleiman’s academic and professional writing has reached a new international milestone, with his articles now appearing on Forbes.com. This development reflects the growing visibility of his work at the intersection of higher education, artificial intelligence, institutional governance, and responsible innovation. One of his recent Forbes Business Council articles, titled “AI In Genomic Medicine Is Advancing—But Institutions Need Governance, Not Hype,” discusses